Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
2018 · Blood · 1,009 citations
https://doi.org/10.1182/blood-2017-09-801498
G
Gerrit Jan Schuurhuis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
202
Papers
9.5K
Citations
44
h-index
95
i10-index
Gerrit Jan Schuurhuis is an academic researcher from Amsterdam University Medical Centers. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Hematopoietic Stem Cell Transplantation & Chronic Myeloid Leukemia Treatments. The author has an h-index of 44, co-authored 172 publications.
ORCID: 0000-0002-0977-6185Papers by this author
worksExosomes Secreted by Apoptosis-Resistant Acute Myeloid Leukemia (AML) Blasts Harbor Regulatory Network Proteins Potentially Involved in Antagonism of Apoptosis
2016 · Molecular & Cellular Proteomics · 88 citations
https://doi.org/10.1074/mcp.m115.052944
Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting
2013 · Blood Cancer Journal · 73 citations
https://doi.org/10.1038/bcj.2013.27
Graft-Versus-Leukemia Effect of Allogeneic Stem-Cell Transplantation and Minimal Residual Disease in Patients With Acute Myeloid Leukemia in First Complete Remission
2017 · JCO Precision Oncology · 34 citations
https://doi.org/10.1200/po.17.00078
Transport proteins in drug resistance: detection and prognostic significance in acute myeloid leukaemia
1997 · Journal of Internal Medicine · 19 citations
https://doi.org/10.1111/joim.1997.242.s740.147
Measurable residual disease in acute myeloid leukemia using flow cytometry: approaches for harmonization/standardization
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7449368
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat